The DNA Library: Understanding Genetics and Diagnosis
At a Glance
Kabuki syndrome is primarily caused by mutations in the KMT2D or KDM6A genes. A definitive diagnosis requires identifying specific physical features, developmental delays, and a confirmed genetic variant. DNA methylation testing can accurately confirm the diagnosis if standard test results are unclear.
Understanding the genetic “blueprint” of Kabuki syndrome can help demystify the diagnosis. While the physical features are what doctors often notice first, the underlying cause is almost always found in how the body manages its genetic instructions.
The Two “Types” of Kabuki Syndrome
Kabuki syndrome is caused by a change (mutation) in one of two specific genes. These genes act like “master switches” or “volume knobs” for other genes in the body [1].
Type 1: KMT2D (The Most Common)
- Frequency: This gene is responsible for approximately 75% of Kabuki syndrome cases [2].
- Inheritance: It follows an autosomal dominant pattern. This means only one copy of the changed gene is needed to cause the syndrome [3].
- Origin: In most individuals, this is a de novo mutation—a random occurrence that was not passed down from either parent [4].
Type 2: KDM6A (The Rarer Type)
- Frequency: This gene accounts for about 5% to 10% of cases [2].
- Inheritance: This is X-linked. Because the gene is located on the X chromosome, the inheritance pattern and way the syndrome appears can differ slightly between males and females [3].
- Origin: This can be a new (de novo) mutation, but importantly, it can also be inherited from a parent, often a mother who may have milder or no obvious symptoms. Therefore, parental genetic testing is critical for family planning [5].
What These Genes Actually Do: “Epigenetics”
Think of your DNA as a massive library of books. Every cell has the same books, but a heart cell needs to read different chapters than a brain cell. Epigenetic regulators—like the proteins made by the KMT2D and KDM6A genes—are the “librarians” [1].
They use chemical tags to mark which “books” (genes) should be open and which should stay closed [6]. When these “librarians” aren’t working correctly, the DNA library becomes disorganized. Genes that should be “turned up” might be “turned down,” leading to the multisystem features of Kabuki syndrome [7][8].
How a “Definitive Diagnosis” is Made
In 2019, an international group of experts created a standard checklist to ensure individuals are diagnosed accurately [2]. A person of any age can receive a definitive diagnosis if they have a history of infantile hypotonia (low muscle tone as a baby) and developmental delay, plus one of the following:
- A Genetic Confirmation: A confirmed pathogenic (disease-causing) variant in either the KMT2D or KDM6A gene [2].
- Specific Physical Features: If genetic testing is not available or is inconclusive, a diagnosis can be made if a person has “typical dysmorphic features” [2]. This includes:
When Sequencing is Unclear: DNA Methylation
Sometimes, standard genetic sequencing finds a “typo” in the gene, but the lab isn’t sure if it actually causes the syndrome. This is called a Variant of Uncertain Significance (VUS) [4].
In these cases, doctors can use a newer technology called DNA methylation profiling (often called an episignature) [9]. This test looks for a specific chemical pattern—a “molecular fingerprint”—on the DNA that is unique to Kabuki syndrome. This test has shown 100% accuracy in identifying the syndrome, providing a “yes” or “no” even when traditional sequencing is fuzzy [9][10].
Checklist: Your Genetic Test Report
When you look at the report, ensure these specific details are present so you can share them with specialists:
- [ ] Gene Name: Does it say KMT2D or KDM6A? [4]
- [ ] Variant Classification: Is it labeled “Pathogenic,” “Likely Pathogenic,” or “Variant of Uncertain Significance”? [4]
- [ ] c. notation (DNA Change): A string of numbers and letters (e.g., c.1234C>T) describing the exact location of the change [11].
- [ ] p. notation (Protein Change): Describes how the protein was altered (e.g., p.Arg412Ter) [11].
- [ ] Zygosity: Usually “Heterozygous,” meaning the change is on only one of the two copies of the gene [4].
- [ ] Inheritance: Does it note if the mutation is “de novo” (new) or if parents were tested? [4]
Common questions in this guide
What genes cause Kabuki syndrome?
Is Kabuki syndrome inherited from parents?
What does a Variant of Uncertain Significance (VUS) mean on my report?
What is DNA methylation or episignature testing?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Is the mutation in the KMT2D or KDM6A gene, and does this change our screening plan?
- 2.Does the genetic report classify this as 'Pathogenic' or a 'Variant of Uncertain Significance' (VUS)?
- 3.If we have a VUS, is DNA methylation (episignature) testing an option to confirm the diagnosis?
- 4.Was this a de novo mutation, or should our family also be tested?
- 5.How does the specific protein change (the 'p.' notation) compare to what is typically seen in Kabuki syndrome?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (11)
- 1
Unveiling the Molecular Landscape of Pancreatic Ductal Adenocarcinoma: Insights into the Role of the COMPASS-like Complex.
Jamali M, Barar E, Shi J
International journal of molecular sciences 2024; (25(10)) doi:10.3390/ijms25105069.
PMID: 38791111 - 2
Kabuki syndrome: international consensus diagnostic criteria.
Adam MP, Banka S, Bjornsson HT, et al.
Journal of medical genetics 2019; (56(2)):89-95 doi:10.1136/jmedgenet-2018-105625.
PMID: 30514738 - 3
Clinical and molecular characteristics of Korean patients with Kabuki syndrome.
Yoon JH, Hwang S, Bae H, et al.
Journal of human genetics 2024; (69(9)):417-423 doi:10.1038/s10038-024-01258-1.
PMID: 38824232 - 4
Case Report: Area of focus clinical presentation and KMT2D gene mutation at the c.15535C>T site in a case of Kabuki syndrome.
Li W, Lin M, Dao J, et al.
Frontiers in genetics 2025; (16()):1523228 doi:10.3389/fgene.2025.1523228.
PMID: 40125530 - 5
De novo exonic deletion of KDM6A in a Chinese girl with Kabuki syndrome: A case report and brief literature review.
Yang P, Tan H, Xia Y, et al.
American journal of medical genetics. Part A 2016; (170(6)):1613-21 doi:10.1002/ajmg.a.37634.
PMID: 27028180 - 6
Molecular insights of KMT2D and clinical aspects of Kabuki syndrome type 1.
Golden CS, Williams S, Serrano MA
Birth defects research 2023; (115(19)):1809-1824 doi:10.1002/bdr2.2183.
PMID: 37158694 - 7
Dissecting KMT2D missense mutations in Kabuki syndrome patients.
Cocciadiferro D, Augello B, De Nittis P, et al.
Human molecular genetics 2018; (27(21)):3651-3668 doi:10.1093/hmg/ddy241.
PMID: 30107592 - 8
KMT2D regulates activation, localization, and integrin expression by T-cells.
Potter SJ, Zhang L, Kotliar M, et al.
Frontiers in immunology 2024; (15()):1341745 doi:10.3389/fimmu.2024.1341745.
PMID: 38765012 - 9
The defining DNA methylation signature of Kabuki syndrome enables functional assessment of genetic variants of unknown clinical significance.
Aref-Eshghi E, Schenkel LC, Lin H, et al.
Epigenetics 2017; (12(11)):923-933 doi:10.1080/15592294.2017.1381807.
PMID: 28933623 - 10
Dohsa-hou intervention for reciprocal interpersonal interaction for a girl with Kabuki syndrome and autism spectrum disorder.
Kawano J, Fujino H
Clinical case reports 2021; (9(6)):e04296 doi:10.1002/ccr3.4296.
PMID: 34194798 - 11
Case report of kabuki syndrome in a newborn caused by KMT2D gene mutation.
Ba X, Yang X, Zhang Y, et al.
Frontiers in pediatrics 2024; (12()):1455609 doi:10.3389/fped.2024.1455609.
PMID: 39678395
This information explains the genetics and diagnostic testing of Kabuki syndrome for educational purposes. Always consult a genetic counselor or medical geneticist to interpret your specific genetic test report and family risks.
Get notified when new evidence is published on Kabuki syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.